Szurián Kinga, Csala Irén, Piurkó Violetta, Deák Linda, Matolcsy András, Reiniger Lilla
1 st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Institute of Behavioural Sciences, Semmelweis University, Budapest, Hungary.
Leuk Res. 2017 Jul;58:39-42. doi: 10.1016/j.leukres.2017.04.002. Epub 2017 Apr 4.
Proliferation centres (PCs) are histological hallmarks of lymph nodes in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL). Chromosomal abnormalities have already been described to accumulate preferably in the PCs as opposed to the intervening small cell areas. To further characterize the pathogenic role of PCs, the expression levels of 17 selected miRs known to be involved in the development of CLL/SLL were compared in the PCs and the intervening small cell areas in lymph nodes of 15 patients with CLL/SLL. The miR expression levels were also compared to the cytogenetic alterations defined by FISH analysis. Our results show that two known oncomiRs, miR-155 and -92a were upregulated and the tumour suppressor miR-150 was downregulated in the PCs. Low expression of miR-150 was also associated with loss of 11q. In summary we found significantly higher expression of oncomiRs and lower expression of a tumour suppressor miR in PCs of CLL/SLL lymph nodes, which support the hypothesis that the PCs may drive the disease and play a role in progression.
增殖中心(PCs)是慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)淋巴结的组织学特征。与中间的小细胞区域相反,染色体异常已被描述为主要在增殖中心累积。为了进一步阐明增殖中心的致病作用,比较了15例CLL/SLL患者淋巴结中增殖中心和中间小细胞区域中17种已知参与CLL/SLL发生发展的miR的表达水平。miR表达水平还与荧光原位杂交(FISH)分析定义的细胞遗传学改变进行了比较。我们的结果显示,在增殖中心,两种已知的致癌miR,即miR-155和-92a上调,而肿瘤抑制miR-150下调。miR-150的低表达也与11q缺失相关。总之,我们发现在CLL/SLL淋巴结的增殖中心,致癌miR表达显著升高,而肿瘤抑制miR表达降低,这支持了增殖中心可能驱动疾病并在疾病进展中起作用的假说。